Related Experiment Video
Updated: Feb 8, 2026

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles
Published on: December 1, 2016
[Development of an Anticancer Therapy Using Recombinant Bifidobacterium as a New Drug Delivery System (DDS)]
Yuichiro Taira1, Ikuko Taira1, Takeshi Nisikawa1
1Department of Pharmaceutical Sciences, Teikyo Heisei University.
Obligate anaerobic bacteria, like Bifidobacterium longum, specifically target tumors due to unique tumor microenvironments. This research explores their use in novel cancer drug delivery systems, offering a safer alternative to traditional methods.
Area of Science:
- Microbiology
- Oncology
- Biotechnology
Background:
- Obligate anaerobic bacteria, including bifidobacteria, exhibit tumor-specific growth.
- Tumor vasculature contains microcracks facilitating bacterial entry.
- Hypoxic tumor microenvironments support anaerobic bacterial survival and proliferation.
Purpose of the Study:
- To investigate the potential of Bifidobacterium longum as a targeted drug delivery vehicle for cancer therapy.
- To develop a novel drug delivery system utilizing Bifidobacterium longum for specific anti-tumor antibody release.
Main Methods:
- Intravenous administration of Bifidobacterium longum.
- Utilizing Bifidobacterium longum's tumor-homing properties for drug delivery.
- Developing antibody-drug conjugates or single-chain antibodies for targeted release.
Main Results:
- Bifidobacterium longum specifically colonizes tumor tissues.
- Gram-positive bifidobacteria do not produce endotoxins, mitigating risks of endotoxin shock.
- Demonstrated potential for targeted delivery of anti-tumor antibodies to tumor sites.
Conclusions:
- Bifidobacterium longum offers a promising platform for targeted cancer drug delivery.
- The system leverages bacterial tropism and the tumor microenvironment for enhanced efficacy and safety.
- This approach presents a novel strategy for developing advanced anti-cancer therapeutics.
Related Concept Videos
Drug Therapy
Antianxiety Medications
Drug Delivery: Overview
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
Drug Delivery: Enteral Route
Drug Delivery: Parenteral Route
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
Drug Delivery: Miscellaneous Routes
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
Drug Administration and Therapy Phases: Overview
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...

